IP Library Granted Patent US 12,471,827
Granted Patent B2
US 12,471,827 · App. 17/026,092 · Granted Nov 18, 2025

ECG based future atrial fibrillation predictor systems and methods

Inventors: Brandon K. Fornwalt (Danville, PA); Christopher Haggerty (Danville, PA); Sushravya Raghunath (Danville, PA); Christopher Good (Danville, PA); John Pfeifer (Lewisburg, PA); Alvaro Ulloa-Cerna (Danville, PA); Arun Nemani (Chicago, IL); Tanner Carbonati (Chicago, IL); Ashraf Hafez (Wheaton, IL)
Assignees: Tempus AI, Inc.; Geisinger Clinic
A61B5/361A61B5/0006A61B5/282G16H10/60G16H50/20G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,471,827
App. No.
17/026,092
Granted
Nov 18, 2025
Kind
B2
Abstract

A method and system for predicting the likelihood that a patient will suffer from atrial fibrillation is provided. The method includes receiving electrocardiogram data associated with the patient, providing at least a portion of the electrocardiogram data to a trained model, receiving a risk score indicative of the likelihood the patient will suffer from atrial fibrillation within a predetermined period of time from when the electrocardiogram data was generated, and outputting the risk score to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator. The system includes at least one processor executing instructions to carry out the steps of the method.

Claims (70)

1 . A method comprising:

receiving electrocardiogram data associated with a subject and an electrocardiogram configuration including a plurality of leads and a time interval, the electrocardiogram data comprising, for each lead included in the plurality of leads, voltage data associated with at least a portion of the time interval;

receiving an age value associated with the subject;

receiving a sex value associated with the subject;

providing the age value, the sex value, and at least a portion of the electrocardiogram data to a trained model, the at least a portion of the electrocardiogram data including first voltage data and second voltage data, the trained model including a first branch having a first convolutional block, a second branch having a second convolutional block, and a concatenation layer configured to generate, based on an output of the first and second branch, a concatenated output, the trained model being trained to generate a risk score based at least in part on the concatenated output and at least one of the age value and the sex value associated with the subject, wherein the first voltage data of the at least a portion of the electrocardiogram data is received at the first branch of the trained model and the second voltage data is received at the second branch of the trained model, the first voltage data consisting of voltage data associated with a first temporal range of the time interval, the second voltage data consisting of voltage data associated with a second, different temporal range of the time interval, and the risk score being generated at least partially based on the first voltage data and the second voltage data;

receiving, from the trained model, the risk score indicative of a likelihood the subject will suffer from a cardiovascular condition within a predetermined period of time from when the electrocardiogram data was generated; and

outputting the risk score to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator,

wherein the trained model is trained using training electrocardiogram data associated with a plurality of training subjects, the plurality of training subjects not having a diagnosis of the cardiovascular condition at the time when the training electrocardiogram data of the training subject was generated.

2 . The method of claim 1 further comprising:

receiving electronic health record data associated with the subject; and

providing at least a portion of the electronic health record data to the trained model.

3 . The method of claim 2 , wherein the electronic health record data comprises at least one of a blood cholesterol measurement, a blood cell count, a blood chemistries lab, a troponin level, a natriuretic peptide level, a blood pressure, a heart rate, a respiratory rate, an oxygen saturation, a cardiac ejection fraction, a cardiac chamber volume, a heart muscle thickness, a heart valve function, a diabetes diagnosis, a chronic kidney disease diagnosis, a congenital heart defect diagnosis, a cancer diagnosis, a procedure, a medication, a referral for cardiac rehabilitation, or a referral for dietary counseling.

4 . The method of claim 1 further comprising:

determining that the risk score is above a predetermined threshold associated with the cardiovascular condition;

in response to determining that the risk score is above the predetermined threshold, generating a report including information and/or links to sources associated with at least one of treatments for the cardiovascular condition or causes of the cardiovascular condition; and

outputting the report to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator.

5 . The method of claim 1 , wherein the period of time is one year.

6 . The method of claim 1 , wherein the period of time is selected from a range of one day to thirty years.

7 . The method of claim 1 , wherein the trained model further comprises a deep neural network comprising a plurality of branches.

8 . The method of claim 7 , wherein each branch of the plurality of branches is associated with a corresponding temporal range of the time interval, and wherein each branch receives voltage data of the portion of the electrocardiogram data consisting of voltage data associated with the temporal range corresponding to the branch of the plurality of branches.

9 . The method of claim 1 , wherein the trained model comprises a deep neural network comprising a convolutional component and a dense layer component.

10 . The method of claim 9 , wherein the convolutional component comprises an inception block comprising a plurality of convolutional layers.

11 . The method of claim 1 , wherein the plurality of leads comprises a lead I, a lead V2, a lead V4, a lead V3, a lead V6, a lead II, a lead VI, and a lead V5.

12 . The method of claim 11 , wherein the electrocardiogram data comprises first voltage data associated with the lead I and a first portion of the time interval, second voltage data associated with the lead V2 and a second portion of the time interval, third voltage data associated with the lead V4 and a third portion of the time interval, fourth voltage data associated with the lead V3 and the second portion of the time interval, fifth voltage data associated with the lead V6 and the third portion of the time interval, sixth voltage data associated with the lead II and the first portion of the time interval, seventh voltage data associated with the lead II and the second portion of the time interval, eighth voltage data associated with the lead II and the third portion of the time interval, ninth voltage data associated with the lead VI and the first portion of the time interval, tenth voltage data associated with the lead VI and the second portion of the time interval, eleventh voltage data associated with the lead VI and the third portion of the time interval, twelfth voltage data associated with the lead V5 and the first portion of the time interval, thirteenth voltage data associated with the lead V5 and the second portion of the time interval, and fourteenth voltage data associated with the lead V5 and the third portion of the time interval.

13 . The method of claim 12 , wherein the time interval comprises a ten second time period, the first portion of the time interval comprises a first half of the time interval, the second portion of the time interval comprises a third quarter of the time interval, and the third portion of the time interval comprises a fourth quarter of the time interval.

14 . The method of claim 12 , wherein the trained model comprises a first channel, a second channel, and a third channel, and the providing step comprises:

providing the first voltage data, the sixth voltage data, the ninth voltage data, and the twelfth voltage data to the first channel;

providing the second voltage data, the fourth voltage data, the seventh voltage data, the tenth voltage data, and the thirteenth voltage data to the second channel; and

providing the third voltage data, the fifth voltage data, the eighth voltage data, the eleventh voltage data, and the fourteenth voltage data to the third channel.

15 . The method of claim 11 , wherein each of the plurality of leads is associated with the time interval.

16 . The method of claim 1 , wherein the electrocardiogram data is indicative of a heart condition based on cardiological standards.

17 . The method of claim 1 , wherein the electrocardiogram data is not indicative of a heart condition based on cardiological standards.

18 . The method of claim 1 , wherein the cardiovascular condition is mortality.

19 . The method of claim 1 , wherein the cardiovascular condition is atrial fibrillation.

20 . A method comprising:

receiving subject electrocardiogram data associated with a subject and an electrocardiogram configuration including a plurality of leads and a time interval from an electrocardiogram device, the subject electrocardiogram data comprising, for each lead included in the plurality of leads, voltage data associated with at least a portion of the time interval;

providing at least a portion of the subject electrocardiogram data to a trained model, the at least a portion of the subject electrocardiogram data including first voltage data consisting of voltage data associated with a first temporal range of the time interval and second voltage data consisting of voltage data associated with a second, different temporal range of the time interval, the trained model including a first branch having a first convolutional block, a second branch having a second convolutional block, and a concatenation layer configured to generate, based on an output of the first and second branch, a concatenated output, the trained model being trained to output a risk score based at least in part on the concatenated output, wherein the first voltage data is received at the first branch of the trained model and the second voltage data is received at the second branch of the trained model, the first branch being configured to receive electrocardiogram data consisting of voltage data associated with the first temporal range, and the second branch being configured to receive electrocardiogram data consisting of voltage data associated with the second temporal range, wherein the first temporal range and the second temporal range do not overlap;

receiving, from the trained model, a risk score indicative of a likelihood the subject will suffer from a cardiovascular condition within a predetermined period of time from when the subject electrocardiogram data was generated;

generating a report based on the risk score; and

outputting the report to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator,

wherein the trained model is trained using training electrocardiogram data associated with a plurality of training subjects, the plurality of training subjects not having a diagnosis of the cardiovascular condition at the time when the training electrocardiogram data of the training subject was generated.

21 . A system, comprising:

at least one processor coupled to at least one memory comprising instructions, the at least one processor executing the instructions to:

receive electrocardiogram data associated with a subject and an electrocardiogram configuration including a plurality of leads and a time interval, the electrocardiogram data comprising, for each lead included in the plurality of leads, voltage data associated with at least a portion of the time interval;

provide at least a portion of the electrocardiogram data to a trained model including a first branch having a first convolutional block, a second branch having a second convolutional block, and a concatenation layer configured to generate, based on an output of the first and second branch, a concatenated output, the at least a portion of the electrocardiogram data including first voltage data and second voltage data, the trained model being trained to output a risk score based at least in part on the concatenated output, wherein the first voltage data is provided to the first branch, the first voltage data being temporally restricted within a first temporal range of the time interval, and the second voltage data is provided to the second branch, the second voltage data being temporally restricted within a second temporal range of the time interval, wherein the second temporal range does not overlap with the first temporal range;

receive, from the trained model, a risk score indicative of a likelihood the subject will suffer from a cardiovascular condition within a predetermined period of time from when the electrocardiogram data was generated from the trained model; and

output the risk score to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator,

wherein the trained model is trained using training electrocardiogram data associated with a plurality of training subjects, the plurality of training subjects not having a diagnosis of the cardiovascular condition at the time when the training electrocardiogram data of the training subject was generated.

22 . A method, comprising:

receiving electrocardiogram data associated with a subject and an electrocardiogram configuration including a plurality of leads and a time interval, the electrocardiogram data comprising, for each lead included in the plurality of leads, voltage data associated with at least a portion of the time interval;

receiving demographic data associated with the subject;

providing a first temporally coherent portion of the electrocardiogram data to a first branch of a trained model the first branch having a first convolutional block, the first temporally coherent portion consisting of first voltage data acquired during a first range of the time interval;

providing a second temporally coherent portion of the electrocardiogram data to a second branch of the trained model, the second branch having a second convolutional block, the second temporally coherent portion consisting of second voltage data acquired during a second range of the time interval, wherein the second range is subsequent to the first range;

providing the demographic data to the trained model;

generating, at the first branch a first output based on the first voltage data, and generating, at the second branch, a second output based on the second voltage data;

concatenating, at a concatenation layer, the first output and the second output with the demographic data;

generating, at the trained model, a risk score indicative of a likelihood the subject will suffer from a cardiovascular condition within a predetermined period of time from when the electrocardiogram data was generated based on the concatenated output and the demographic data;

receiving the risk score from the trained model; and

outputting the risk score to at least one of a memory or a display for viewing by a medical practitioner or healthcare administrator,

wherein the trained model is trained using training electrocardiogram data associated with a plurality of training subjects, the plurality of training subjects not having a diagnosis of the cardiovascular condition at the time when the training electrocardiogram data of the training subject was generated.

23 . The method of claim 22 , wherein the demographic data comprises a sex of the subject.

24 . The method of claim 22 , wherein the demographic data comprises an age of the subject.

25 . The method of claim 22 , wherein the cardiovascular condition is mortality.

26 . The method of claim 22 , wherein the cardiovascular condition is atrial fibrillation.

27 . The method of claim 22 , wherein the time period is at least six months.

28 . The method of claim 27 , wherein the time period is at least one year.

29 . The method of claim 22 , wherein the plurality of leads comprises a lead I, a lead V2, a lead V4, a lead V3, a lead V6, a lead II, a lead VI, and a lead V5.

30 . The method of claim 22 further comprising:

generating a report based on the risk score; and

outputting the report to the display for viewing by a medical practitioner or healthcare administrator.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded May 13, 2026
From: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
To: TEMPUS AI, INC. (F/K/A TEMPUS LABS, INC.)
Reel/Frame 075608/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2025
From: FORNWALT, BRANDON K.; HAGGERTY, CHRISTOPHER; RAGHUNATH, SUSHRAVYA
To: GEISINGER CLINIC
Reel/Frame 072003/0961 →
CHANGE OF NAME Recorded Jan 12, 2024
From: TEMPUS LABS
To: TEMPUS AI, INC.
Reel/Frame 066302/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2022
From: NEMANI, ARUN; CARBONATI, TANNER; HAFEZ, ASHRAF
To: TEMPUS LABS, INC.
Reel/Frame 061842/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2022
From: PFEIFER, JOHN; ULLOA CERNA, ALVARO
To: GEISINGER CLINIC
Reel/Frame 061716/0128 →
SECURITY INTEREST Recorded Sep 22, 2022
From: TEMPUS LABS, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 061506/0316 →
Continuity (4)
Provisional Application 63013897 · Apr 22, 2020
Provisional Application 62924529 · Oct 22, 2019
Provisional Application 62902266 · Sep 18, 2019
Related Publication 20210076960A1 · Mar 18, 2021
References Cited (138)
US 7801591B1 · Shusterman · 2010 [cited by applicant]
US 10395772B1 · Lucas · 2019 [cited by applicant]
US 10667680B2 · Gupta et al. · 2020 [cited by applicant]
US 10827982B2 · Sitek · 2020 [cited by applicant]
US 11972869B2 · Wagner et al. · 2024 [cited by applicant]
US 20070214013A1 · Silverman · 2007 [cited by applicant]
US 20090093686A1 · Hu et al. · 2009 [cited by applicant]
US 20100217144A1 · Brian · 2010 [cited by examiner]
US 20110295134A1 · DeBauche · 2011 [cited by applicant]
US 20150112182A1 · Sharma et al. · 2015 [cited by applicant]
US 20150235143A1 · Eder · 2015 [cited by applicant]
US 20150324527A1 · Siegel et al. · 2015 [cited by applicant]
US 20160022162A1 · Ong · 2016 [cited by applicant]
US 20160135706A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160256064A1 · Estes, Jr. · 2016 [cited by applicant]
US 20170357756A1 · Fidone et al. · 2017 [cited by applicant]
US 20180033063A1 · Milne · 2018 [cited by applicant]
US 20180249965A1 · Spangler · 2018 [cited by applicant]
US 20180333104A1 · Sitek · 2018 [cited by applicant]
US 20180368723A1 · Ibáñez Català · 2018 [cited by examiner]
US 20190171936A1 · Karras · 2019 [cited by examiner]
US 20190237160A1 · Rothberg et al. · 2019 [cited by applicant]
US 20200176122A1 · Teplitzky et al. · 2020 [cited by applicant]
US 20200226757A1 · Hare, II et al. · 2020 [cited by applicant]
US 20200337773A1 · Rawlinson et al. · 2020 [cited by applicant]
US 20200353271A1 · Dani et al. · 2020 [cited by applicant]
US 20200397313A1 · Attia et al. · 2020 [cited by applicant]
US 20210000347A1 · Stump · 2021 [cited by applicant]
US 20210027194A1 · Monaghan et al. · 2021 [cited by applicant]
US 20210059540A1 · Peterson et al. · 2021 [cited by applicant]
US 20210076960A1 · Fornwalt et al. · 2021 [cited by applicant]
US 20210085215A1 · Auerbach et al. · 2021 [cited by applicant]
US 20210085397A1 · Passerini et al. · 2021 [cited by applicant]
US 20210089921A1 · Aghdasi et al. · 2021 [cited by applicant]
US 20210110930A1 · Park et al. · 2021 [cited by applicant]
US 20210125722A1 · Sherkat et al. · 2021 [cited by applicant]
US 20210150693A1 · Fornwalt et al. · 2021 [cited by applicant]
US 20210153761A1 · Jung et al. · 2021 [cited by applicant]
US 20210259560A1 · Venkatraman et al. · 2021 [cited by applicant]
US 20210345934A1 · Landgraf et al. · 2021 [cited by applicant]
US 20220189636A1 · Wagner et al. · 2022 [cited by applicant]
US 20220229071A1 · Rhyne et al. · 2022 [cited by applicant]
US 20240164688A1 · Asirvatham et al. · 2024 [cited by applicant]
CN 106510686A · 2017 [cited by applicant]
JP 2009522068A · 2009 [cited by applicant]
JP 2011514831A · 2011 [cited by applicant]
JP 2014150826A · 2014 [cited by applicant]
JP 2015525413A · 2015 [cited by applicant]
JP 2019514635A · 2019 [cited by applicant]
KR 20200077852A · 2020 [cited by applicant]
WO 2019070978A1 · 2019 [cited by applicant]
WO 2019118640A1 · 2019 [cited by applicant]
WO 2020004369A1 · 2020 [cited by applicant]
WO 2021071142A1 · 2021 [cited by applicant]
Can machine-learning improve cardiovascular risk prediction using routine clinical data; Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N (2017), Plos One 12(4): e0174944. https://doi.org/10.1371/journal.pone.017494 (Yea… [cited by examiner]
L. D. Nguyen, D. Lin, Z. Lin and J. Cao, “Deep CNNs for microscopic image classification by exploiting transfer learning and feature concatenation,” 2018 IEEE International Symposium on Circuits and Systems (ISCAS), Flo… [cited by examiner]
Feng, K.; Pi, X.; Liu, H.; Sun, K. Myocardial Infarction Classification Based on Convolutional Neural Network and Recurrent Neural Network. Appl. Sci. 2019, 9, 1879. https://doi.org/10.3390/app9091879 (Year: 2019). [cited by examiner]
Alonso A, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2. [cited by applicant]
Attia Zi, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet. 2019;394:861-867. [cited by applicant]
Britton, M. et al. “Non-rheumatic atrial fibrillation as a risk factor for stroke.” Stroke 16.2 (1985): 182-188. [cited by applicant]
Chamberlain AM, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] Study). Am J Cardiol. 2011;107:85-91. [cited by applicant]
Chen T, et al. Xgboost: A scalable tree boosting system. In: Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. ACM; 2016. p. 785-794. [cited by applicant]
clinicaltrials.gov. A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke. NCT04126486. clinicaltrials.gov. 2019. [cited by applicant]
clinicaltrials.gov. Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (East). NCT01288352. clinicaltrials.gov. 2011. [cited by applicant]
Connolly SJ, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151. [cited by applicant]
Cox DR. Regression Models with Life Tables. J R Stat Soc Ser B. 1972. [cited by applicant]
Duchi J, et al. Adaptive subgradient methods for online learning and stochastic optimization. In: The Journal of Machine Learning Research. 2011. p. 2121-2159. [cited by applicant]
Friberg, L et al. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45:2599-2605. [cited by applicant]
Gopinathannair R, et al. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. J Am Coll Cardiol. 2015;66:1714-1728. [cited by applicant]
Granger CB, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992. [cited by applicant]
Guo Y, et al. Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation. J Am Coll Cardiol. 2019. [cited by applicant]
Hannon N, et al. “Stroke associated with atrial fibrillation—incidence and early outcomes in the north Dublin population stroke study.” Cerebrovascular Diseases 29.1 (2010): 43-49. [cited by applicant]
Hart RG, et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med. 2007;146:857-867. [cited by applicant]
Healey JS, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129. [cited by applicant]
Heeringa J, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J. 2006. [cited by applicant]
Hobbs FDR, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people a… [cited by applicant]
Huizar JF, et al. Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2019;73:2328-2344. [cited by applicant]
International Searching Authority. International Search Report and Written Opinion for application PCT/US2020/051655. Mailed on Dec. 22, 2020. 8 pages. [cited by applicant]
Ioffe S, et al. Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift. 2015; Available from: http://arxiv.org/abs/1502.03167. [cited by applicant]
Kaplan EL, et al. Nonparametric Estimation from Incomplete Observations. Am Stat Assoc. 1958;53:457-481. [cited by applicant]
Kirchhof P, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016;37. [cited by applicant]
Koltowski L, et al. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center. Ca… [cited by applicant]
Kottkamp H. Human atrial fibrillation substrate: Towards a specific fibrotic atrial cardiomyopathy. Eur. Heart J. 2013;34:2731-2738. [cited by applicant]
Krahn AD, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-484. [cited by applicant]
Lin HJ, et al. Newly diagnosed atrial fibrillation and acute stroke: The framingham study. Stroke. 1995;26:1527-1530. [cited by applicant]
Lin M, et al. Network in network. In: 2nd International Conference on Learning Representations, ICLR 2014—Conference Track Proceedings. 2014. [cited by applicant]
Lip Gyh, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest. 2010;… [cited by applicant]
Lloyd-Jones DM, et al. Lifetime risk for development of atrial fibrillation: The framingham heart study. Circulation. 2004;110:1042-1046. [cited by applicant]
Meschia JF, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754-3832. [cited by applicant]
Morandi A, et al. X-ray, lensing and Sunyaev-Zel'dovich triaxial analysis of Abell 1835 out to R 200. Mon Not R Astron Soc. 2012;425:2069-2082. [cited by applicant]
Page RL, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994;89:224-227. [cited by applicant]
Patel MR, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891. [cited by applicant]
Perez M V., et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381:1909-1917. [cited by applicant]
Prechelt L. Early stopping-but when? In: Neural Networks: Tricks of the trade. Springer; 1998. p. 55-69. [cited by applicant]
Raghunath, S., et al. “Deep neural networks can predict mortality from 12-lead electrocardiogram voltage data.” arXiv preprint arXiv:1904.07032 (2019). [cited by applicant]
Raghunath, S., et al. (2020). Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network. Nature medicine, 26(6), 886-891. [cited by applicant]
Reiffel JA, et al. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: The Reveal AF study. JAMA Cardiol. 2017;2:1120-1127. [cited by applicant]
Rembold CM. Number needed to screen: Development of a statistic for disease screening. Br Med J. 317.7154 (1998): 307-312. [cited by applicant]
Schnabel RB, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373:739-745. [cited by applicant]
Schroder FH, et al. Screening and prostate-cancer mortality in a randomized european study. N Engl J Med. 2009;360:1320-1328. [cited by applicant]
Siu AL. Screening for breast cancer: U.S. Preventive services task force recommendation statement. Ann. Intern. Med. 2016;164:279-296. [cited by applicant]
Steinhubl SR, et al. Effect of a home-Based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation the mSTOPS randomized clinical trial. JAMA—J Am Med Assoc. 2018;320:146-155. [cited by applicant]
Stewart S, et al. A Population-Based Study of the Long-term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew/Paisley Study. 2002. The American journal of medicine 113.5 (2002): 359-364. [cited by applicant]
Turakhia MP, et al. Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm from Cardiac Electronic Implanted Devices. Circ Arrhythmia Electrophysiol. 2015… [cited by applicant]
Wolf PA, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. 1978. Neurology 28.10 (1978): 973-973. [cited by applicant]
Youden WJ. Index for rating diagnostic tests. Cancer. 1950. 32-35. [cited by applicant]
Arvanitis et al., Identification of V1221 (Val122lle) Transthyretin Cardiac Amyloidosis (ATTR) Using Serum Retinol-Binding Protein 4 (RBP4) and a Clinical Prediction Model, JAMA Cardiol., 2017, 2(3):305-313. [cited by applicant]
Ashburner et al., Design and Rationale of a Pragmatic Trial Integrating Routine Screening for Atrial Fibrillation at Primary Care Visits: The VITAL-AF Trial, American Heart Journal, 2019, 215:147-156. [cited by applicant]
Freedman et al., Stroke Prevention in Atrial Fibrillation, The Lancet, 2016, 388(10046):806-817. [cited by applicant]
Gladstone et al., Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial, JAMA Cardiology, 2021, 6(5):558-567. [cited by applicant]
Hindricks et al., 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal, 2020, 4… [cited by applicant]
Huda et al., A Machine Learning Model for Identifying Patients at Risk for Wild-Type Transthyretin Amyloid Cardiomyopathy, Nature Communications, 2021, 12:2725, pp. 1-12. [cited by applicant]
Khurshid et al., ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation, Circulation, 2022, 145(2):122-133. [cited by applicant]
Kyriakou et al., Diagnosis of Cardiac Amyloidosis: A Systematic Review on the Role of Imaging and Biomarkers, BMC Cardiovascular Disorders, 2018, 18:221, pp. 1-11. [cited by applicant]
Martini et al., Deep Learning to Diagnose Cardiac Amyloidosis from Cardiovascular Magnetic Resonance, Journal of Cardiovascular Magnetic Resonance, 2020, 22:84, pp. 1-11. [cited by applicant]
Poterucha et al., Deep Learning Analysis of Cardiac Testing for the Detection of Cardiac Amyloidosis, JACC, 2021, 77(18):529. [cited by applicant]
Raghunath et al., Deep Neural Networks can Predict New-Onset Atrial Fibrillation from the 12-lead ECG and Help Identify Those at Risk of Atrial Fibrillation-Related Stroke, Circulation, 2021, 143(13):1287-1298. [cited by applicant]
Singer et al., ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and Design of the GUARD-AF Randomized Trial of Screening for Atrial Fibrillation with a 14-day… [cited by applicant]
Suresh et al., Advanced Cardiac Amyloidosis Associated with Normal Interventricular Septum Thickness: An Uncommon Presentation of Infiltrative Cardiomyopathy, J Am Soc Echocardiogr, 2014, 27(4):440-447. [cited by applicant]
Svennberg et al., Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study, Circulation, 2015, 131(25):2176-2184. [cited by applicant]
Topol, Digital Medicine—What's Lurking in Your Electrocardiogram?, The Lancet, 2021, 397:785. [cited by applicant]
US Preventive Services Task Force, Screening for Atrial Fibrillation, US Preventive Services Task Force Recommendation Statement, JAMA, 2022, 327(4):360-367. [cited by applicant]
Weimann et al., Transfer Learning for ECG Classification, Scientific Reports, 2021, 11:5251, pp. 1-12. [cited by applicant]
Wolf et al., Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study, Stroke, 1991, 22(8):983-988. [cited by applicant]
PCT International Search Report and Written Opinion, PCT/US2022/031663, Aug. 19, 2022, 15 pages. [cited by applicant]
PCT International Search Report and Written Opinion, PCT/US2022/031665, Aug. 19, 2022, 16 pages. [cited by applicant]
PCT International Search Report and Written Opinion, PCT/US2022/031670, Aug. 18, 2022, 9 pages. [cited by applicant]
Apple Inc., De Novo Classification Request for ECG App, 2018, 15 pages. [cited by applicant]
Canadian Intellectual Property Office, Office Action, Application No. 3,151,064, Jan. 3, 2024, 6 pages. [cited by applicant]
European Patent Office, Extended Search Report, Application No. 20866017.5, Sep. 20, 2023, 7 pages. [cited by applicant]
Feng, Kai, et al. “Myocardial infarction classification based on convolutional neural network and recurrent neural network.” Applied Sciences 9.9 (2019): 1879. (pp. 1-12). [cited by applicant]
Nguyen, L. D., Lin, D., Lin, Z., & Cao, J. (May 2018). Deep CNNs for microscopic image classification by exploiting transfer learning and feature concatenation. In 2018 IEEE international symposium on circuits and syste… [cited by applicant]
Office Action in Canadian Application No. 3,151,064; received on Sep. 16, 2024. [cited by applicant]
Office Action in Japanese Application No. 2022-518201; received on Nov. 11, 2024. [cited by applicant]
Notice of Preliminary Rejection in Korean Application No. 10-2022-7012295; received on Apr. 26, 2025. [cited by applicant]
Liu, Yixiu, et al. “Detecting premature ventricular contraction in children with deep learning.” Journal of Shanghai Jiaotong University (Science) 23 (2018): 66-73. [cited by applicant]
Miller, Andrew C., Ziad Obermeyer, and Sendhil Mullainathan. “A comparison of patient history-and ekg-based cardiac risk scores.” AMIA Summits on Translational Science Proceedings 2019 (2019): 82. [cited by applicant]
Second Office Action in Japanese Patent Application No. 2022-518201; received on Jun. 10, 2025. [cited by applicant]